Tvardi Therapeutics (TVRD) Could Be 2025’s Most Democratic Biotech Stock
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) is a clinical-stage biotechnology company redefining the boundaries of targeted therapy through its pioneering…
Anavex (AVXL) Gains as $120M Cash Fuels Next Alzheimer’s & Schizophrenia Trials
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a cutting-edge clinical-stage biopharmaceutical company focused on discovering and developing novel therapies…
Aldeyra Therapeutics (ALDX) Falls Below $5.40 as FDA Decision Looms
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) is a Massachusetts-based clinical-stage biotechnology company focused on discovering and developing novel therapies designed…
Fresenius Medical (FMS) Hovers Near $22 — But For How Long?
Fresenius Medical Care AG (NYSE:FMS) is the world’s leading provider of dialysis products and services for individuals with…
Labcorp (LH) Trades Near $210 as Investors Bet on 82% Earnings Boom
Laboratory Corporation of America Holdings (NYSE: LH), commonly known as Labcorp, is one of the world’s leading global…
Axogen (AXGN) Surges Toward $26 Target as Nerve Repair Demand Soars 17%
Axogen Inc. (NASDAQ:AXGN) is a leading regenerative medicine company focused on advancing the science and clinical practice of…
Emergent BioSolutions (EBS) Faces Investor Pressure After Revenue Drops to $0.81B TTM
Emergent BioSolutions Inc. (NYSE:EBS) is a global life sciences company headquartered in Gaithersburg, Maryland, known for developing, manufacturing,…
Aclarion (ACON) Emerges as Rising Star in AI Diagnostics at HLTH 2025 Awards
Aclarion, Inc. (NASDAQ:ACON) is a healthcare technology company pioneering the use of advanced biomarkers and augmented intelligence to…
UnitedHealth (UNH) Posts $111.62B Q2 Revenue But Earnings Disappoint
UnitedHealth Group Incorporated (NYSE:UNH) stands as one of the largest and most influential healthcare companies in the world,…
Quoin Pharmaceuticals (QNRX) Soars 138% After $104.5M Funding Deal
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) is a late clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative therapies…
ARS Pharmaceuticals (SPRY)’s $250M Deal Signals Big Bet on Needle-Free Allergy Treatment
ARS Pharmaceuticals (NASDAQ:SPRY) is a commercial-stage biopharmaceutical company headquartered in San Diego, California, focused on revolutionizing the emergency…
Argenx SE (ARGX) Hits $803.95 All-Time High After 88% Revenue Surge
Argenx NV (NASDAQ:ARGX) is a global immunology biotechnology company founded in 2008 in the Netherlands with a mission…
Universe Pharmaceuticals (UPC) Stock Soars 56%
Universe Pharmaceuticals Inc. (NASDAQ:UPC) is a China-based pharmaceutical company that develops, manufactures, markets, and distributes traditional Chinese medicine…
Turn Therapeutics (TTRX)’s NASDAQ Debut Sends Stock Up 134%
Turn Therapeutics Inc. (NASDAQ:TTRX) is a biotechnology and medical device company founded to revolutionize how therapies are delivered…
Elevance Health (ELV) Down 14.6% YTD
Elevance Health, Inc. (NYSE:ELV) is one of the largest and most influential health insurance and managed care companies…
Teladoc Health (TDOC) Gains 12.5% Analyst Price Target Boost to $9.00
Teladoc Health, Inc. (NYSE:TDOC) is a global leader in virtual healthcare, pioneering a new model of digital-first medicine…
Tarsus Pharmaceuticals (TARS) Skyrockets 10.9% After $181M XDEMVY Sales Surge
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is a rapidly emerging biopharmaceutical company transforming the eye health industry through first-in-class therapies…
Tempest Therapeutics (TPST) Boosts Cash With $4.6M Raise Ahead of Cancer Trial
Tempest Therapeutics, Inc. (NASDAQ:TPST) is a clinical-stage biotechnology company pioneering dual-action cancer therapies that combine direct tumor targeting…